Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 16,830 shares at $50.38 ($844K) on 2015-06-01, disclosed to the SEC on 2015-06-02.
Scheduled sale ($844k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.07 | 11,875 | $595K | 70.4% |
| 2 | $50.38 | 4,955 | $250K | 29.6% |
| Total | $50.16 avg | 16,830 | $844K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |